Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-07-31

FDA Approved: MYOBLOC — Supplemental Application (Solstice Neurosciences, LLC)

View source ↗

Summary

The FDA approved a supplemental application for MYOBLOC (rimabotulinumtoxinB) from Solstice Neurosciences, LLC. This action confirms approval under the sponsor'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYOBLOC (rimabotulinumtoxinB)

Snippet

SUPPL AP for MYOBLOC (RIMABOTULINUMTOXINB)